NHS National Generics Pharmaceuticals - Supply Chain Resilience
NHS England is establishing a framework to supply generic oral and non-parenteral medicines (Lot 1) and hospital-only generics (Lot 2) to regional NHS networks. Suppliers will be called off to provide these products over 21 or 13 months starting September 2026.
- Closed2 March 2026
- Value£52m
- Per lot£26m across 2 lots
- BuyerNHS England
- Wheremultiple NHS regions across England
- CategoryHealth & medical
- RegionUK-wide
You'll want to look if you manufacture or distribute generic pharmaceutical products and can supply to NHS regional networks across England
Might not suit a small firm
- the contract itself is a large one
- it needs coverage across the whole UK
Possible incumbent
Many suppliers including Accord UK Ltd, Kent Pharma Ltd, Martindale Pharma, Mercury Pharmaceuticals, Milpharm Ltd, Pfizer Ltd, Teva UK Limited, and Zentiva Pharma UK Ltd won the most recent NHS National Generic Pharmaceuticals Wave 15c in January 2026. Inferred from prior awards to this buyer, not confirmed.